海外の治験の状況「1」での検索結果
544件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- A Phase 2, Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Second- or Third-line Treatment of Subjects With Unresectable Pleural or Peritoneal Malignant Mesothelioma
- Unresectable Pleural or Peritoneal Malignant Mesothelioma;C45.0 - Mesothelioma of pleura;C45.1 - Mesothelioma of peritoneum
- Australia, Canada, United States
- 2013-08-16
Recruiting
- Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer
- Small Cell Lung Cancer;Small Cell Lung Cancer
- Australia, Brazil, Canada, Germany, Sweden, United Kingdom, United States
- 2017-11-03
Recruiting
- Children with HIV in Africa – pharmacokinetics and acceptability of simple second-line antiretroviral regimens
- HIV Infections and Infestations Human immunodeficiency virus [HIV] disease
- Uganda, Zambia, Zimbabwe
- 2017-10-20
Recruiting
- A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC
- Non-Small Cell Lung Cancer
- Argentina, Australia, Belgium, Brazil, Canada, Chile, China, France, Germany, Ireland, Italy, Japan, Mexico, Poland, Romania, Russian Federation, Spain, United Kingdom, United States
- 2017-07-11
Recruiting
- A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)
- Small Cell Lung Cancer
- Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, China, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2017-01-25
Recruiting
- SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma
- Intrahepatic Cholangiocarcinoma
- Australia, Belgium, France, Germany, Italy, Netherlands, Spain, United Kingdom, United States
- 2016-05-13
Recruiting
- Pharmacometric Optimization of Second Line Drugs for MDR Tuberculosis Treatment
- Multidrug-resistant Tuberculosis;Multidrug-resistant Tuberculosis;Multidrug-resistant Tuberculosis
- South Africa
- 2016-03-29
Recruiting
- A study to test an oral combination of letrozole and everolimus for patients with advanced lung cancer who have progressed on first line chemotherapy.
- Non Small Cell lung cancer
- Australia
- 2007-04-20
Recruiting
- A Randomised Phase II Study Of nab-paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas
- Gastrointestinal Neuroendocrine Carcinomas
- Australia, New Zealand
- 2016-07-21
Recruiting
- A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
- Carcinoma, Non-Small-Cell Lung
- Argentina, Australia, Belgium, Canada, China, Czechia, Denmark, France, Germany, Hong Kong, India, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Singapore, Spain, Taiwan, Turkey, United Kingdom, United States
- 2017-01-20